Worksport (NASDAQ:WKSP) versus Aspire Biopharma (NASDAQ:ASBP) Critical Contrast

Worksport (NASDAQ:WKSP) and Aspire Biopharma (NASDAQ:ASBP) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations for Worksport and Aspire Biopharma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Worksport	1	0	1	0	2.00
Aspire Biopharma	1	0	0	0	1.00

Worksport presently has a consensus price target of $2.00, indicating a potential upside of 466.25%. Given Worksport’s stronger consensus rating and higher probable upside, analysts plainly believe Worksport is more favorable than Aspire Biopharma.

Risk & Volatility

Worksport has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. Comparatively, Aspire Biopharma has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500.

Valuation and Earnings

This table compares Worksport and Aspire Biopharma”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Worksport	$16.10 million	0.44	-$19.35 million	($2.34)	-0.15
Aspire Biopharma	$97,659.00	126.14	-$24.48 million	($69.62)	-0.13

Worksport has higher revenue and earnings than Aspire Biopharma. Worksport is trading at a lower price-to-earnings ratio than Aspire Biopharma, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Worksport and Aspire Biopharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Worksport	-114.49%	-102.57%	-73.69%
Aspire Biopharma	-11,362.21%	N/A	-177.59%

Insider & Institutional Ownership

16.1% of Worksport shares are owned by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are owned by institutional investors. 5.8% of Worksport shares are owned by insiders. Comparatively, 5.8% of Aspire Biopharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Worksport beats Aspire Biopharma on 10 of the 14 factors compared between the two stocks.

About Worksport

Worksport Ltd., through its subsidiary, designs and distributes truck tonneau covers in Canada and the United States. The company offers soft tonneau covers, such as vinyl wrapped tri- and quad-fold tonneau covers; and hard tonneau covers, including tri- and quad-fold aluminum covers. It also offers energy products, such as Worksport SOLIS, a tonneau cover with integrated solar panels; and Worksport COR energy storage system, a modular, portable power station. It serves its products to automotive accessories, consumer electronics, and residential and commercial HVAC system markets. The company also sells its products through wholesalers, private labels, distributors, and online retail channels, including eBay, Amazon, Walmart, and e-commerce platform hosted on Shopify. Worksport Ltd. is based in West Seneca, New York.

About Aspire Biopharma

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company provides Sublingual Aspirin Product, which addresses cardiology emergencies and pain management. It develops formulation for a sublingually administered melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide, as well as formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and several other classes of drugs. The company was founded in 2021 and is based in Humacao, Puerto Rico.